The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: -3.50 (-0.20%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: FTSE called to open lower ahead of Fed and BoE minutes

Wed, 20th Nov 2013 07:33

City sources predict the FTSE 100 will open around 21 points lower than yesterday's close of 6,698.01, ahead of the release of the minutes from both the Bank of England and the latest meeting of the US Federal Reserve. The Federal Open Market Committee's meeting should offer further insight behind the Fed's decision to maintain its monetary stimulus programme. Last month the Fed said it would keep interest rates near zero and its monthly $85bn bond buying programme unchanged until the economy and jobs market improved further. The President of the Federal Reserve Bank of New York said on Monday that he was "getting more hopeful" about the economic recovery, citing labour market improvements and stronger-than-expected growth in the third quarter."Given that he is typically dovish, these comments have been taken by investors as a warning that the Fed will soon begin to wind down its asset purchase program," said Craig Erlam, Market Analyst at Alpari UK, yesterday.This morning he added: "It was no surprise when the Fed left policy unchanged last month, but investors will be looking for hints about when policy makers intend to taper. If there is still a lot of support for tapering this year, it could lead to a December taper being heavily priced in, especially if this is paired with data that suggests the economy was unaffected by the shutdown." Elsewhere, Philadelphia Fed President Charles Plosser said the Fed should set a fixed dollar amount on its monetary easing and end bond purchases when that amount is reached."We cannot continue to play this bond-buying game by ear and risk the Fed's credibility while creating lingering uncertainty about the course of monetary policy," he said in a speech before the Risk Management Association in Philadelphia.Many economists expect the Fed to announce a tapering of quantitative easing to $70bn a month in March, although uncertainty remains.Today's agenda will also be jam packed with economic data with the release of US retail sales, manufacturing inventories and mortgage applications. Back on this side of the Pond, the Bank of England will release minutes of its interest rate decision. The central bank last month announced it would keep interest rates at 0.5% and asset purchases at £375bn. Investors will today be looking to see if the BoE has shown any signs that policy makers favour a new unemployment threshold. In company news, infrastructure investor HICL Infrastructure said net asset value rose 3.2p per share for the first half of its financial year and said the pipeline of potential new investment opportunities under evaluation remains promising. NAV per share, post-interim dividend, rose to 119.6p from 116.4p at March 31st.GlaxoSmithKline has completed the partial sale of Aspen Pharmacare, the drug company announced this morning. The group has disposed 28.2m ordinary shares in Aspen at a price of 250 South African Rand (ZAR) per share, raising gross proceeds of 7,059 ZAR.Utilities reseller Telecom Plus has completed an acquisition of Npower's gas and electricity supply businesses that catapults it into big league of UK utilities. The FTSE 250 company, which operates via the Utility Warehouse brand and uses customers as distributors, has agreed a price of £218m, which it will fund via a share placing and new debt.NR
More News
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.